| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| % of revenue | 83.6% | 86.4% | ||
| Operating costs and expenses | ||||
| Research and development expenses | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Total operating loss | ||||
| % of revenue | -168.4% | -835.6% | ||
| Finance income (expenses) | — | |||
| Loss before taxes on income | ||||
| Taxes on income | — | |||
| Net loss for the period | ||||
| % of revenue | -185.6% | -761.1% | ||
| Loss per share attributable to common shareholders | ||||
| Basic loss per share | ||||
| Diluted loss per share |